Project Details
Description
A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803, a Novel Recombinant IL-15 Complex in Patients with Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/16 → 12/31/19 |
Funding
- FRED HUTCHINSON CANCER CENTER
- ALTOR BIOSCIENCE LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.